The prevalence of metabolic syndrome in patients suffering from non valvular atrial fibrillation is derived from studies regarding recurrences of atrial fibrillation after catheter ablation. Prospective studies in european countries are stil lacking. Furthermore the impact of metabolic syndrome on cardiovascular events in patients with non valvular atrial fibrillation is still unknown.